News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
728,042 Results
Type
Article (45868)
Company Profile (300)
Press Release (681874)
Multimedia
Podcasts (79)
Webinars (12)
Section
Business (211764)
Career Advice (2544)
Deals (36940)
Drug Delivery (108)
Drug Development (83955)
Employer Resources (181)
FDA (16769)
Job Trends (15591)
News (359372)
Policy (34586)
Tag
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (6)
Academia (2717)
Academic (1)
Accelerated approval (5)
Adcomms (22)
Allergies (91)
Alliances (51900)
ALS (94)
Alzheimer's disease (1420)
Antibody-drug conjugate (ADC) (135)
Approvals (16764)
Artificial intelligence (268)
Autoimmune disease (24)
Automation (16)
Bankruptcy (376)
Best Places to Work (11912)
BIOSECURE Act (20)
Biosimilars (113)
Biotechnology (190)
Bladder cancer (78)
Brain cancer (29)
Breast cancer (282)
Cancer (2307)
Cardiovascular disease (184)
Career advice (2112)
Career pathing (32)
CAR-T (154)
Cell therapy (435)
Cervical cancer (19)
Clinical research (67994)
Collaboration (864)
Compensation (531)
Complete response letters (26)
COVID-19 (2732)
CRISPR (46)
C-suite (251)
Cystic fibrosis (106)
Data (2220)
Decentralized trials (2)
Denatured (28)
Depression (46)
Diabetes (282)
Diagnostics (6535)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (124)
Drug pricing (114)
Drug shortages (29)
Duchenne muscular dystrophy (94)
Earnings (88558)
Editorial (41)
Employer branding (21)
Employer resources (154)
Events (116153)
Executive appointments (742)
FDA (18039)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (762)
Gene editing (113)
Generative AI (21)
Gene therapy (324)
GLP-1 (766)
Government (4669)
Grass and pollen (5)
Guidances (59)
Healthcare (19274)
Huntington's disease (24)
IgA nephropathy (28)
Immunology and inflammation (127)
Indications (30)
Infectious disease (2878)
Inflammatory bowel disease (141)
Inflation Reduction Act (8)
Influenza (52)
Intellectual property (99)
Interviews (470)
IPO (16941)
IRA (48)
Job creations (4101)
Job search strategy (1768)
Kidney cancer (10)
Labor market (39)
Layoffs (502)
Leadership (22)
Legal (8571)
Liver cancer (76)
Lung cancer (324)
Lymphoma (157)
Machine learning (7)
Management (63)
Manufacturing (319)
MASH (68)
Medical device (13615)
Medtech (13620)
Mergers & acquisitions (20537)
Metabolic disorders (720)
Multiple sclerosis (80)
NASH (17)
Neurodegenerative disease (97)
Neuropsychiatric disorders (31)
Neuroscience (1983)
NextGen: Class of 2025 (6789)
Non-profit (4623)
Now hiring (39)
Obesity (389)
Opinion (250)
Ovarian cancer (76)
Pain (95)
Pancreatic cancer (84)
Parkinson's disease (151)
Partnered (21)
Patents (244)
Patient recruitment (111)
Peanut (50)
People (59617)
Pharmaceutical (92)
Pharmacy benefit managers (20)
Phase I (21111)
Phase II (29908)
Phase III (22408)
Pipeline (1202)
Policy (153)
Postmarket research (2683)
Preclinical (9211)
Press Release (68)
Prostate cancer (107)
Psychedelics (31)
Radiopharmaceuticals (251)
Rare diseases (403)
Real estate (6303)
Recruiting (69)
Regulatory (23511)
Reports (47)
Research institute (2440)
Resumes & cover letters (418)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (76)
Series A (133)
Series B (86)
Service/supplier (13)
Sickle cell disease (56)
Special edition (17)
Spinal muscular atrophy (152)
Sponsored (30)
Startups (3775)
State (2)
Stomach cancer (14)
Supply chain (70)
Tariffs (44)
The Weekly (49)
Vaccines (732)
Venture capitalists (43)
Weight loss (265)
Women's health (35)
Worklife (19)
Date
Today (163)
Last 7 days (865)
Last 30 days (2678)
Last 365 days (33586)
2025 (10832)
2024 (36021)
2023 (40900)
2022 (52144)
2021 (56736)
2020 (55333)
2019 (48121)
2018 (36406)
2017 (33636)
2016 (33237)
2015 (39201)
2014 (33042)
2013 (28138)
2012 (30271)
2011 (30994)
2010 (28907)
Location
Africa (850)
Alabama (53)
Alaska (7)
Arizona (243)
Arkansas (14)
Asia (41493)
Australia (6742)
California (6163)
Canada (2026)
China (541)
Colorado (268)
Connecticut (274)
Delaware (151)
Europe (89154)
Florida (913)
Georgia (207)
Idaho (57)
Illinois (548)
India (26)
Indiana (316)
Iowa (11)
Japan (167)
Kansas (106)
Kentucky (24)
Louisiana (10)
Maine (70)
Maryland (905)
Massachusetts (4631)
Michigan (236)
Minnesota (392)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (63)
New Hampshire (63)
New Jersey (1740)
New Mexico (29)
New York (1750)
North Carolina (990)
North Dakota (8)
Northern California (2688)
Ohio (205)
Oklahoma (14)
Oregon (39)
Pennsylvania (1386)
Puerto Rico (12)
Rhode Island (33)
South America (1231)
South Carolina (22)
South Dakota (1)
Southern California (2303)
Tennessee (101)
Texas (916)
United States (23370)
Utah (182)
Virginia (153)
Washington D.C. (61)
Washington State (560)
West Virginia (3)
Wisconsin (56)
728,042 Results for "ani pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ANI Pharmaceuticals Announces the Launch of Nitazoxanide Tablets
March 19, 2025
·
6 min read
Press Releases
ANI Pharmaceuticals Announces Buyout of Royalty Obligation for ILUVIEN® and YUTIQ®
March 18, 2025
·
5 min read
Press Releases
ANI Pharmaceuticals to Present at 2025 RBC Capital Markets Ophthalmology Virtual Conference
March 31, 2025
·
1 min read
Press Releases
ANI Pharmaceuticals Announces FDA Approval for Expansion of ILUVIEN® Label
March 14, 2025
·
12 min read
BioMidwest
ANI Pharmaceuticals Announces the Launch of Kionex® Suspension
ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the launch of Kionex ® (Sodium Polystyrene Sulfonate Suspension USP) for Oral or Rectal use.
May 20, 2024
·
4 min read
Press Releases
ANI Pharmaceuticals to Present at the Guggenheim Biotech Conference
January 28, 2025
·
1 min read
BioMidwest
ANI Pharmaceuticals to Present at the 2024 Jefferies Global Healthcare Conference
ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, will present at the 2024 Jefferies Global Healthcare Conference in New York City.
May 29, 2024
·
1 min read
Press Releases
ANI Pharmaceuticals to Discuss First Quarter 2025 Financial Results on May 9, 2025, at 8:00 a.m. ET
April 10, 2025
·
1 min read
Press Releases
ANI Pharmaceuticals Announces FDA Approval of New Purified Cortrophin Gel® Prefilled Syringe
March 3, 2025
·
9 min read
BioMidwest
ANI Pharmaceuticals Announces the Launch of Baclofen Oral Suspension
ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the launch of Baclofen Oral Suspension, a generic version of the reference listed drug (RLD) Fleqsuvy ® .
April 9, 2024
·
4 min read
1 of 72,805
Next
